Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2018.
The company has reported a net loss of Rs 38.68 crore for the quarter under review against net profit of Rs 320.65 crore for the same quarter in the previous year. Total income of the company decreased by 6.26% at Rs 2289.02 crore for Q3FY19 as compared Rs 2441.90 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported around 4-fold jump in its net profit at Rs 1,241.85 crore for the quarter under review as compared to Rs 321.57 crore for the same quarter in the previous year. Total income of the company increased by 16.97% at Rs 7,933.25 crore for Q3FY19 as compared Rs 6,782.42 crore for the corresponding quarter previous year.
